Humanin: the mitochondrial peptide longevity researchers study
Your mitochondria do more than generate energy — they produce signaling peptides that researchers think may influence how cells age.
TL;DR
- Humanin is a 24-amino-acid peptide encoded in mitochondrial DNA (mtDNA) and is the founding member of a class called MDPs (mitochondrial-derived peptides).
- Research in animals and human cell models associates humanin with cytoprotection (cell survival under stress), reduced oxidative stress, and changes in markers linked to aging.
- Humanin is a real, endogenous peptide. It is not FDA-approved as a drug and is not commercially available.
What is humanin
Humanin is a 24-amino-acid peptide — and it is unusual because of where it comes from. Most proteins and peptides are encoded in nuclear DNA, inside the cell's nucleus. Humanin is encoded in mitochondrial DNA (mtDNA — in plain English: the separate set of genetic instructions housed inside the mitochondria). Specifically, it sits within a region called 16S rRNA. It is the founding member of a class researchers call MDPs (mitochondrial-derived peptides: signaling molecules that come from mitochondria). Related MDPs include MOTS-c and a family called SHLPs. Humanin was first identified in 2001 in research on cell survival.
How does humanin work
Think of humanin as a distress signal your mitochondria send out when a cell is under stress. When energy production is disrupted or a cell is pushed toward apoptosis (in plain English: programmed self-destruction), humanin is released. It binds to receptors on the outer membrane of the cell and in circulation. This binding is linked to blocking the apoptosis cascade and reducing oxidative stress (in plain English: damage from unstable molecules that degrade cellular components). It also modulates inflammatory signals. Because mitochondria are present in almost every cell in the body, humanin's receptor targets span multiple tissues — including neurons, cardiac muscle, and metabolic tissue. This breadth of action is part of what makes it interesting to longevity researchers.
Who asks about it
People come to this topic through two main paths. One is interest in mitochondrial biology. These are readers who have learned that mitochondria decline with age and want to know what the body does in response. The other path is longevity research broadly. Humanin appears in discussions of cellular-stress-response pathways, and people who have encountered those conversations often want to understand the specific molecules involved.
What the research says
A 2020 study in Aging found that overexpressing humanin in C. elegans — the roundworm widely used in aging research — extended lifespan. The effect depended on the daf-16/FOXO pathway, a conserved longevity-signaling route. In mice, humanin administration beginning in midlife was associated with decreased markers of cognitive decline and reduced overall inflammation (Yen et al., Aging, 2020). A separate mouse study found that chronic humanin supplementation was linked to reduced age-related cardiac fibrosis. It also showed a decrease in apoptosis markers in heart tissue (Thummasorn et al., PubMed, 2018). These are animal and model findings. Large-scale human clinical trials do not yet exist, and no human efficacy conclusions can be drawn from the current evidence base.
What to know before considering it
Humanin is not FDA-approved in any form. There is no commercially available humanin product — no licensed compounded version, no approved pharmaceutical. The research to date is predominantly in animal models and cell cultures, with some observational correlative work in humans. The gap between animal findings and human clinical outcomes is meaningful and well-documented in peptide research. Accessing any investigational compound in a clinical context requires the involvement of a licensed physician and, in most cases, participation in a formal research setting.
The Halftime POV
Humanin is one of those topics where the biology is genuinely compelling and the evidence is still early. It is a real molecule the body produces. It comes from an organelle — the mitochondrion — that is increasingly central to aging science. The research trajectory is worth watching. At Halftime Health, we follow this literature because understanding what the body already does to protect itself is foundational to proactive medicine. That capacity changes with age, and tracking it matters. We will keep covering it as the science develops.
Related reading:
- What is a peptide? A plain-English primer
- Four peptide families: a practical classification
- Autophagy: what it is and why it matters for longevity
- Urolithin A and mitophagy: what the longevity research shows
FAQ
Q: What is humanin? A: Humanin is a 24-amino-acid peptide encoded within mitochondrial DNA — specifically in the 16S ribosomal RNA region. It belongs to a class called MDPs (mitochondrial-derived peptides), meaning it is made inside mitochondria rather than in the cell nucleus like most proteins. It is a research-stage molecule, not an FDA-approved drug.
Q: How does humanin work? A: Humanin is studied as a cytoprotective signal — in plain English, a molecule that helps cells survive under stress. It is associated with blocking apoptosis (programmed cell death), reducing oxidative stress, and modulating inflammation. It acts on receptors found in multiple tissues and appears to communicate between mitochondria and the rest of the cell and body.
Q: Is humanin a real peptide? A: Yes. Humanin is a well-documented endogenous peptide — meaning the body produces it naturally. It was first described in 2001 and has since been studied in peer-reviewed research in humans, mice, and other organisms. It is real but it is not a drug: there is no FDA-approved humanin product and no commercially marketed form.
Q: What is the difference between humanin and MOTS-c? A: Both are MDPs (mitochondrial-derived peptides) encoded in mitochondrial DNA, but they are distinct molecules with different sequences, different receptor targets, and different areas of research focus. Humanin is the older, more-studied of the two. MOTS-c has attracted attention for its association with metabolic regulation and exercise response. Researchers sometimes study them together as part of the broader MDP family.
Disclaimer
This article is educational and is not medical advice. Compounded medications are not FDA-approved. Clinical outcomes depend on individual factors and require physician evaluation. Results vary. Halftime Health is launching soon — join the waitlist to get updates.
Get updates
Halftime Health is launching soon. We'll share what we learn along the way — the research, the regulations, the real-world trade-offs. Join the waitlist and we'll email you when we're live.
Sources
- Yen K et al., "The mitochondrial derived peptide humanin is a regulator of lifespan and healthspan," Aging (2020)
- Thummasorn S et al., "Chronic treatment with the mitochondrial peptide humanin prevents age-related myocardial fibrosis in mice," PubMed (2018)
Frequently asked questions
What is humanin?
Humanin is a 24-amino-acid peptide encoded within mitochondrial DNA — specifically in the 16S ribosomal RNA region. It belongs to a class called MDPs (mitochondrial-derived peptides), meaning it is made inside mitochondria rather than in the cell nucleus like most proteins. It is a research-stage molecule, not an FDA-approved drug.
How does humanin work?
Humanin is studied as a cytoprotective signal — in plain English, a molecule that helps cells survive under stress. It is associated with blocking apoptosis (programmed cell death), reducing oxidative stress, and modulating inflammation. It acts on receptors found in multiple tissues and appears to communicate between mitochondria and the rest of the cell and body.
Is humanin a real peptide?
Yes. Humanin is a well-documented endogenous peptide — meaning the body produces it naturally. It was first described in 2001 and has since been studied in peer-reviewed research in humans, mice, and other organisms. It is real but it is not a drug: there is no FDA-approved humanin product and no commercially marketed form.
Keep reading
A licensed physician can build a protocol from your own labs.
Membership from $69/mo, including your onboarding panel. Each protocol is its own monthly subscription.